FANG
发表于 2025-3-26 23:29:08
B cell targets in rheumatoid arthritis,atients with RA using the first licensed agent, rituximab. Recent research has focused on enhancing efficacy using other targets to inhibit B cell function, including other B cell-depleting antibodies and cytokines critical to B cell function. The rationale for new B cell targets is discussed, as well as clinical data.
易弯曲
发表于 2025-3-27 01:27:47
http://reply.papertrans.cn/67/6659/665854/665854_32.png
撤退
发表于 2025-3-27 06:10:51
http://reply.papertrans.cn/67/6659/665854/665854_33.png
dithiolethione
发表于 2025-3-27 11:33:54
http://reply.papertrans.cn/67/6659/665854/665854_34.png
邪恶的你
发表于 2025-3-27 14:17:52
New Therapeutic Targets in Rheumatoid Arthritis978-3-7643-8238-4Series ISSN 1422-7746 Series E-ISSN 2296-4525
Irritate
发表于 2025-3-27 19:14:23
Paul-Peter TakFocuses on therapeutic targets that have recently been registered or are currently under development..Each chapter discusses the biological rationale in great detail including results from clinical tr
言外之意
发表于 2025-3-27 22:04:12
Role of IL-1 in erosive arthritis, lessons from animal models,e therapeutic target, in addition to TNF and IL-6. However, IL-1 dependency can be lost under conditions of T cell IL-17 abundance as well as the presence of Toll-like receptor ligands. The latter may underlie the variable responsiveness of rheumatoid arthritis patients to anti-cytokine therapy and warrants combination therapy for optimal control.
Fantasy
发表于 2025-3-28 03:42:13
http://reply.papertrans.cn/67/6659/665854/665854_38.png
僵硬
发表于 2025-3-28 09:48:22
http://reply.papertrans.cn/67/6659/665854/665854_39.png
peritonitis
发表于 2025-3-28 10:41:29
IL-17 and Th17 cells, key players in arthritis, results previously obtained following the identification of IL-17 as a T cell-derived cytokine. At the same time, additional information was obtained on the other members of the IL-17 family and on the structure of the IL-17 receptor complex. Such knowledge has further extended the choice of possible modalities to control IL-17.